686P Next generation sequencing (NGS) helps predict response to immunotherapy (IO) in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)

686P Next generation sequencing (NGS) helps predict response to immunotherapy (IO) in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; pp. S856 - S857
Main Authors: Mirallas, O., Marmolejo Castaneda, D.H., Illescas, D.G., Gómez-Puerto, D., Berché, R., Calvo, A.H., Vieito Villar, M., Lorini, L., Navarro, V., Assaf Pastrana, J.D., Saavedra, O., Alonso, G., Aguilar Izquierdo, S., Bescós, C., Lorente, J., Giralt, J., Dienstmann, R., Garralda, E., Felip, E., Brana, I.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.810